The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa is a Gram-negative opportunistic bacterial pathogen that is refractory to a variety of current antimicrobial therapeutic regimens. Complicating treatment for such infections is the ability of P. aeruginosa to form biofilms, as well as several innate and acquired resistance mechanisms. Previous studies suggest iron plays a role in resistance to antimicrobial therapy, including the efficacy of an FDA-approved iron chelator, deferasirox (DSX), or Gallium, an iron analog, in potentiating antibiotic-dependent killing of P. aeruginosa biofilms. Here, we show that iron-replete conditions enhance resistance of P. aeruginosa nonbiofilm growth against tobramycin and tigecycline. Interestingly, the mechanism of iron-enhanced resistance to each of these antibiotics is distinct. Whereas pyoverdine-mediated iron uptake is important for optimal resistance to tigecycline, it does not enhance tobramycin resistance. In contrast, heme supplementation results in increased tobramycin resistance, while having no significant effect on tigecycline resistance. Thus, nonsiderophore bound iron plays an important role in resistance to tobramycin, while pyoverdine increases the ability of P. aeruginosa to resist tigecycline treatment. Lastly, we show that iron increases the minimal concentration of tobramycin, but not tigecycline, required to eradicate P. aeruginosa biofilms. Moreover, iron depletion blocks the previous observed induction of biofilm formation by subinhibitory concentrations of tobramycin, suggesting iron and tobramycin signal through overlapping regulatory pathways to affect biofilm formation. These data further support the role of iron in P. aeruginosa antibiotic resistance, providing yet another compelling case for targeting iron acquisition for future antimicrobial drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026 · cited 3×
“Several studies demonstrate that high-iron concentrations favor the formation of biofilms (Singh et al., 2002; Singh, 2004; Banin et al., 2005; Berlutti et al., 2005; Moreau-Marquis et al., 2008; Patriquin et al., 2008), and a recent report shows iron released from CF airway epithelial cells promotes biofilm formation…”
BackgroundSiderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584 · cited 2×
“Binding of ferripyoverdine to its outer membrane receptor, FpvA, releases PvdS, which is normally sequestered at the inner membrane by its anti-sigma factor, FpvR (Lamont et al., 2002, Beare et al., 2003).”
BackgroundSelf-citationOchsner, U. A., Johnson, Z., & Vasil, M. L. (2000) · Microbiology · doi:10.1099/00221287-146-1-185 · Cited by 310 · cited 2×
“iron from heme, an abundant source of host iron, via at least two systems: Phu (Pseudomonas heme uptake) and Has (heme assimilation system) (Ochsner et al., 2000).”
BackgroundSelf-citationFerrous Iron Is a Significant Component of Bioavailable Iron in Cystic Fibrosis Airways
Hunter, R. C., Asfour, F., Dingemans, J., Osuna, B. L., Samad, T., Malfroot, A., Cornelis, P., & Newman, D. K. (2013) · mBio · doi:10.1128/mbio.00557-13 · Cited by 173
Iron metabolism in the lower respiratory tract
Mateos, F., Brock, J. H., & Perez-Arellano, J. L. (1998) · Thorax · doi:10.1136/thx.53.7.594 · Cited by 158
STITES, S. W., PLAUTZ, M. W., BAILEY, K., O'BRIEN-LADNER, A. R., & WESSELIUS, L. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9811018 · Cited by 109
Cited by
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Eze, E., Chenia, H., & El Zowalaty, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s169894 · Cited by 264
Klebba, P. E., Newton, S. M. C., Six, D. A., Kumar, A., Yang, T., Nairn, B. L., Munger, C., & Chakravorty, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01005 · Cited by 150
Reinhart, A. A., Powell, D. A., Nguyen, A. T., O'Neill, M., Djapgne, L., Wilks, A., Ernst, R. K., & Oglesby-Sherrouse, A. G. (2015) · Infection and Immunity · doi:10.1128/iai.02707-14 · Cited by 97
Self-citation
Metadata
- Authors
- Oglesby-Sherrouse, A. G., Djapgne, L., Nguyen, A. T., Vasil, A. I., & Vasil, M. L.
- Venue
- Pathogens and Disease
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-10
- Volume
- 70
- Issue
- 3
- Pages
- 307-320
- ISSN
- 2049-632X (ISSN-L)
- OpenAlex
- W1963885628
- Cited by
- 86
- References
- 6
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. https://app.cochat.ai/papers/10.1111/2049-632x.12132
- The paper
- Oglesby-Sherrouse, A. G., Djapgne, L., Nguyen, A. T., Vasil, A. I., & Vasil, M. L. (2014). The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. Pathogens and Disease. https://doi.org/10.1111/2049-632x.12132
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.